Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), maintenance of normal blood LDL cholesterol concentrations (ID 1135, 1704a, 3093a), reduction of vasomotor symptoms associated with menopause (ID 1654, 1704b, 2140, 3093b, 3154, 3590), maintenance of normal skin tonicity (ID 1704a), contribution to normal hair growth (ID 1704a, 4254), “cardiovascular health” (ID 3587), treatment of prostate cancer (ID 3588) and “upper respiratory tract” (ID 3589) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Meta data
Keywords
Soy isoflavones, oxidative damage, cholesterol, skin tonicity, hair growth, vasomotor symptoms, menopause, prostate cancer, cardiovascular health, upper respiratory tract, health claims
On request from
European Commission
Question Number
EFSA-Q-2008-1874
EFSA-Q-2008-2024
EFSA-Q-2008-2440
EFSA-Q-2008-3825
EFSA-Q-2008-4312
EFSA-Q-2008-4313
EFSA-Q-2008-4314
EFSA-Q-2008-4955
EFSA-Q-2008-4964
EFSA-Q-2008-2390
EFSA-Q-2008-05018
EFSA-Q-2008-2873
EFSA-Q-2008-05019
EFSA-Q-2008-3886
EFSA-Q-2008-4315
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Contact
Abstract
No abstract available
© European Food Safety Authority, 2011